1. Home
  2. FOSL vs RNA Comparison

FOSL vs RNA Comparison

Compare FOSL & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

N/A

Current Price

$5.24

Market Cap

265.3M

ML Signal

N/A

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

N/A

Current Price

$12.27

Market Cap

222.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOSL
RNA
Founded
1984
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.3M
222.5M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
FOSL
RNA
Price
$5.24
$12.27
Analyst Decision
Strong Buy
Buy
Analyst Count
1
20
Target Price
$7.00
$69.26
AVG Volume (30 Days)
896.7K
114.7K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
25.26
N/A
EPS
N/A
N/A
Revenue
$1,004,406,000.00
N/A
Revenue This Year
N/A
$88.12
Revenue Next Year
$1.66
$18.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$11.13
52 Week High
$6.16
$73.06

Technical Indicators

Market Signals
Indicator
FOSL
RNA
Relative Strength Index (RSI) 58.77 52.55
Support Level $3.70 $11.95
Resistance Level $5.75 $14.05
Average True Range (ATR) 0.43 0.35
MACD 0.06 0.12
Stochastic Oscillator 59.22 80.44

Price Performance

Historical Comparison
FOSL
RNA

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: